ofloxacin and zithromax

ofloxacin has been researched along with zithromax in 154 studies

Research

Studies (154)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	17 (11.04)	18.2507
2000's	94 (61.04)	29.6817
2010's	38 (24.68)	24.3611
2020's	5 (3.25)	2.80

Authors

Authors	Studies
Jolivette, LJ; Nagilla, R; Ward, KW	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Hanaki, H; Maseda, H; Nakae, T; Sugimura, M	1
Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M	1
Goy, G; Greub, G	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Glen, RC; Lowe, R; Mitchell, JB	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Barreca, ML; Cannalire, R; Cecchetti, V; Couto, I; Felicetti, T; Machado, D; Manfroni, G; Massari, S; Sabatini, S; Santos Costa, S; Tabarrini, O; Viveiros, M	1
Andersson, CD; Elofsson, M; Eriksson, AU; Gylfe, Å; Mojica, S; Saleeb, M	1
Kirchner, JT	1
Hammerschlag, MR; Qumei, KK; Roblin, PM	1
Børsum, T; Dannevig, L; Melby, K; Størvold, G	1
Citron, DM; Goldstein, EJ; Nesbit, CA	1
Bow, LM; Nicolau, DP; Nightingale, CH; Onyeji, CO; Tessier, PR	1
Johnson, RE; Weber, JT	1
Mann, RD; Pearce, GL; Wilton, LV	1
Citron, DM; Claros, MC; Goldstein, EJ; Hunt Gerardo, S	1
Appelbaum, PC; Jacobs, MR; Visalli, MA	1
Hammerschlag, MR; Kutlin, A; Roblin, PM	3
Chen, C; Danziger, LH; Martin, SJ; Pendland, SL; Schreckenberger, PC	1
Edelstein, PH	1
Citron, DM; Goldstein, EJ; Hudspeth, M; Hunt Gerardo, S; Merriam, CV	1
Appelbaum, PC; Jacobs, MR; Lin, G; Spangler, SK	1
Potts, JM; Rackley, RR; Ward, AM	1
Bhullar, VB; Black, CM; Farshy, CE; Somani, J; Workowski, KA	1
Brieland, JK; Hare, RS; Loebenberg, D; Menzel, F	1
Chinh, NT; Diep, TS; Farrar, JJ; Ha, HD; Ly, NT; Parry, CM; Thong, MX; Wain, J; White, NJ	1
Coleman, EJ; Mandell, GL	1
Bush, K; Fogarty, C; Goldschmidt, R	1
Forest, G; Henry, M; Oldach, D; Simsir, A	1
Doyle, E; Edelstein, MA; Edelstein, PH; Shinzato, T	1
Ishii, Y; Kobayashi, T; Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K	1
Chimura, T	1
Bosso, JA; Enzweiler, KA; Friedrich, LV; Hoban, D; Wagner, D; White, RL	1
Bahal, N; Frank, E; Freitag, S; Kahn, JB; Kinasewitz, G; Liu, J; Moran, GJ; Olson, WH; Oross, MP; Reichl, V; Tennenberg, A; Wiesinger, BA	1
Ikegaya, S; Inoue, H; Iwasaki, H; Takagi, K; Ueda, T	1
Cabria, F; Esteban, J; Fernández-Roblas, R; Gadea, I; Rollan, E; Santos-O'Connor, FG; Soriano, F; Torres, MV	1
Hammerschlag, MR; Kutlin, A; Reznik, T; Roblin, PM	1
Katouno, Y; Kobayashi, Y; Sugita, K; Uchida, H	1
Amsden, GW; Baird, IM; Simon, S; Treadway, G	1
Malcolm, C; Marrie, TJ	1
Critchley, IA; Evangelista, AT; Jones, ME; Karlowsky, JA; Noel, GJ; Sahm, DF; Thornsberry, C	1
Danziger, LH; Gotfried, MH; Rodvold, KA	1
Itoh, Y; Kikuchi, K; Nakanishi, K; Nakao, S; Ohsaki, Y; Osanai, S; Saito, K; Sato, M; Tachibana, M; Takahashi, T; Toyoshima, E	1
Shen, M; Zhao, Y; Zhou, LQ	1
Hasegawa, M; Kobayashi, I; Matsuzaki, K; Sato, Y; Shikano, M; Watabe, E; Yamanaka, N; Yoshimori, K	1
Huang, C; Li, J; Lin, N; Liu, Z; Tu, Y; Zhang, D	1
Adachi, JA; DuPont, HL; DuPont, MW; Ericsson, CD; Jiang, ZD; Knirsch, C; Martinez-Sandoval, F	1
Lobzin, IuV; Pozniak, AL; Volzhanin, VM	1
Inoue, K; Kumakura, S; Tsutsui, T; Uchida, M	1
Braman, S; Capitano, B; Mattoes, HM; Nicolau, DP; O'Brien, A; Shore, E; Sutherland, C	1
Daschner, F; Schmidt-Eisenlohr, E; Wenzler, S	1
Hammerschlag, MR; Hawser, S; Islam, K; Kohlhoff, SA; Reznik, T; Roblin, PM	1
Hammerschlag, MR; Roblin, PM	1
Good, CE; Jakielaszek, C; Koeth, LM; Saunders, KA	1
Marrie, TJ	1
Arenoso, H; Bantar, C; Caruso, N; Fernández Canigia, L; Nicola, F; Soutric, J	1
Alou, L; Cafini, F; Prieto, J; Sevillano, D; Valero, E	1
Brian, SR; Kimbrough, RC	1
Caronzolo, D; Colleoni, F; Fraschini, F; Grosso, S; Lucini, V; Pannacci, M; Scaglione, F	1
Abdulla, RH; Amsden, GW; Andrews, CP; de Caprariis, PJ; Knirsch, CA; Lode, H; Mandell, LA; McIvor, A; Niederman, MS; Vrooman, PS; Zervos, M	1
Berry, V; Hoover, J; Singley, C; Woodnutt, G	1
Armstrong, EP; Malone, DC; Ramachandran, S; Skrepnek, GH	1
De Vecchi, E; Drago, L; Legnani, D; Nicola, L; Prenna, M; Ripa, S	1
Consolazio, A; Crispino, P; Iacopini, F; Nardi, F; Palladini, D; Paoluzi, OA; Paoluzi, P; Pica, R; Rivera, M	1
Fugit, RV; Glasheen, JJ; Prochazka, AV	1
Breen, JD; Emparanza, P; Lesinskas, E; Murray, JJ; Tawadrous, M	1
Marple, BF	1
Breen, JD; Camere, MA; D'Ignazio, J; Jorgensen, D; Lewis, DE	1
Angus, DC; Milbrandt, EB	1
Harnett, J; Matchar, DB; Samsa, GP; Wilson, J	1
Cho, YK; Jeon, WK; Kang, MS; Kim, BI; Kim, HJ; Oh, SY; Park, DI; Park, JH; Sohn, CI; Yoo, TW; Yun, JW	1
Blasi, F; Tarsia, P	1
Martinez, FJ	1
Hadley, JA	1
Lück, PC; Steinert, M	1
Pedro-Botet, L; Yu, VL	1
Mikamo, H; Tamaya, T; Tanaka, K; Watanabe, K	1
Appelbaum, PC; Bozdogan, B; Choi, DR; Credito, K; Dewasse, B; Kosowska-Shick, K; Lin, G; McGhee, P; Pankuch, GA; Ryu, JM	1
Adam, HJ; Laing, N; Mayer, M; Zhanel, GG	1
Aguilar, L; Alou, L; Cafini, F; Echeverría, O; Giménez, MJ; Pérez-Trallero, E; Prieto, J; Sevillano, D	1
Komori, K; Nakada, N; Suzuki, Y; Tanaka, H; Yasojima, M	1
Hand, DL; Hand, WL; Vasquez, Y	1
García-Cruz, A; Mateu, L; Pedro-Botet, ML; Rey-Joly, C; Roure, S; Sabria, M; Sopena, N; Tural, C	1
Bay, PV; Farrar, JJ; Hien, TT; Ho, VA; Lanh, MN; Parry, CM; Phuong, le T; Tham, NT; Tung, le T; Wain, J	1
Armstrong, A; Baqar, S; Bodhidatta, L; Faix, DJ; Fox, A; Hshieh, P; Lawler, JV; Lebron, C; Lewis, M; Maley, EA; Mason, C; Nayak, G; Pang, LW; Pitarangsi, C; Sanders, JW; Scott, DA; Tribble, DR	1
DuPont, HL	1
Ambruzs, M; Kahn, JB; Khashab, M	1
Haggerty, CL; Ness, RB	2
Gagnon, C; García-Ac, A; Ghosh, D; Lajeunesse, A; Sauvé, S; Segura, PA	1
D'Acremont, V; Genton, B	1
Erkin, G; Isik, SR; Kalyoncu, AF; Karakaya, G	1
Appelbaum, PC; Clark, CL; Ednie, LM; Kosowska-Shick, K	1
LaPlante, KL; Mersfelder, TL; Quilliam, BJ; Ward, KE	1
de Caprariis, PJ; Marple, BF; Reisman, A; Roberts, CS	1
Aguilar, L; Alou, L; Echeverría, O; Giménez, MJ; González, N; Martín, JE; Prieto, J; Sevillano, D; Torrico, M; Valdés, L	1
Beckius, ML; Fraser, SL; Galloway, RL; Griffith, ME; Hospenthal, DR; Mende, K; Miller, RS; Murray, CK; Pimentel, G; Ressner, RA	1
Frenck, RW; Johnston, JR; Monteville, MR; Putnam, SD; Riddle, MS; Rockabrand, DM; Sanders, JW; Tribble, DR; Ulukan, S	1
Dubrovskaia, NV; Dvoretskiĭ, LI; Filimonova, OIu; Grudinina, SA; Iakovlev, SV; Sidorenko, SV	1
Chen, HW; Lai, CC; Tan, CK	1
Noguchi, Y	1
Attridge, RT; Fisher, A; Frei, CR; Jaso, TC; Makos, BR; Mody, SH; Mortensen, EM; Oramasionwu, CU; Raut, MK; Restrepo, MI; Ruiz, AD; Ruiz, JL; Schein, JR	1
Ambruzs, M; Fisher, AC; Nord, CE; Peterson, J	1
Biernat-Sudolska, M; Drzewiecki, A; Rojek-Zakrzewska, D	1
Rapp, RP	1
Cao, B; Chen, YS; Gu, L; Li, XW; Liang, L; Liang, ZA; Lu, HZ; Lu, LH; Mao, Y; Wang, C; Wang, DY; Wang, J; Zhang, B; Zhang, SJ	1
Carratalà, J; Garcia-Vidal, C	1
Castanheira, M; Jones, RN; Woosley, LN	1
Arnold, F; Griffin, AT; Peyrani, P; Wiemken, T	1
Baddour, LM; Edelstein, PH; Han, JH; Harada, S; Nguyen, JC	1
Baldelli, R; Cevenini, R; D'Antuono, A; Delucca, F; Di Francesco, A; Donati, M; Moroni, A; Shurdhi, A	1
Bobyleva, ZD; Leshchenko, IV	1
Garlaschi, MC; Magri, V; Markotić, A; Marras, E; Perletti, G; Restelli, A; Skerk, V	1
Hashimoto, J; Hayashi, K; Ichihara, K; Iwasawa, A; Kurimura, Y; Satoh, T; Sunaoshi, K; Suzuki, N; Takahashi, S; Takeda, K; Tsukamoto, T	1
Ishii, Y; Kimura, S; Sato, T; Tateda, K; Yamaguchi, K	1
Kim, SJ; Toma, HS	1
An, J; Hao, XY; Li, ZS; Wang, GC; Zuo, GY	1
Baik, GH; Jung, HC; Kim, GH; Kim, HB; Kim, JM; Kim, JY; Kim, NY; Kim, SJ; Lee, DH; Nam, RH; Song, IS	1
Dan, M; Rosenberg, S; Samra, Z	1
Dave, SB; Kim, SJ; Toma, HS	2
Arjyal, A; Baker, S; Basnyat, B; Dongol, S; Farrar, JJ; Karkey, A; Koirala, KD; Shrestha, UM; Thanh, DP; Thapa, SD	1
Azana, R; Boos, A; Conley, ME; Crawford, RI; Deans, GD; Hoang, L; Janz, L; Junker, A; Leo, SH; Morton, TL; Prendiville, J; Senger, C; Tilley, P; Turvey, SE	1
Bian, ZQ; Han, J; Li, Y; Wang, GC; Zhang, YL; Zuo, GY	1
Bourret, A; Brun, JL; Fauconnier, A	1
Andreeva, IV; Belikov, AN; Evstaf'ev, VV; Fokin, AA; Grinev, AV; Khrianin, AA; Kirpicheva, NN; Korolev, SV; Kozlov, SN; Serdiutskaia, MV; Stetsiuk, OU	1
Chaudhry, R; Dhawan, B; Khanna, N; Malhotra, N; Mittal, S; Rawre, J; Sreenivas, V	1
Aboud, C; Algood, H; Boyd, AS; Braun, N; Burke, VE; Drake, WP; Isom, J; Kaminski, N; King, LE; Oswald-Richter, K; Pandit, KV; Richmond, BW; Taylor, T; Yu, C	1
Berlutti, F; Frioni, A; Natalizi, T; Pantanella, F; Valenti, P	1
Fujii, R; Ishihara, K; Narita, M; Okuda, K; Shibahara, T; Takano, N	1
Luo, Q; Shi, C; Wang, X; Wu, J; Yu, N	1
Bouscarat, F; Dupin, N; Janier, M; Spenatto, N; Vermersch-Langlin, A; Vernay-Vaisse, C	1
Alcaraz, I; Caumes, E; Dupin, N; Janier, M; Maatouk, I; Timsit, FJ	1
File, TM; LaPlante, K; Llop, CJ; Tillotson, GS; Tuttle, E	1
Arjyal, A; Baker, S; Basnyat, B; Darton, T; Dolecek, C; Dongol, S; Farrar, JJ; Karkey, A; Thompson, CN; Thwaites, GE; Wolbers, M	1
Alzate, JP; Gaitán, HG; González, LM; Lethaby, A; Páez-Canro, C; Rubio-Romero, JA	1
Acharya, B; Arjyal, A; Karki, M; Marasini, B; Pokharel, S	1
Dean, G; Pitt, R; Ross, J; Sabin, C; Soni, S; Whetham, J	1
Arun, S; Chakraborty, P; Gaonkar, O; Neppolian, B; Xin, L; Zhang, G	1
Basnyat, B; Darton, TC; Eyre, D; Kuehn, R; Parry, CM; Stoesser, N	1
Jiang, B; Jing, XL; Li, GA; Li, SS; Ling, WC; Sui, SS; Sun, CY; Wang, YL	1

Reviews

15 review(s) available for ofloxacin and zithromax

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
New treatments for Chlamydia trachomatis genital infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 20 Suppl 1 Topics: Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Male; Ofloxacin; Pregnancy; Pregnancy Complications, Infectious	1995
Value of short-course antimicrobial therapy in community-acquired pneumonia. International journal of antimicrobial agents, 2005, Volume: 26 Suppl 3 Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Microspheres; Ofloxacin; Pneumonia; Time Factors; Treatment Outcome	2005
Acute exacerbation of chronic bronchitis: expanding short-course therapy. International journal of antimicrobial agents, 2005, Volume: 26 Suppl 3 Topics: Acute Disease; Aged; Anti-Bacterial Agents; Azithromycin; Bronchitis; Clinical Trials as Topic; Confidence Intervals; Double-Blind Method; Drug Administration Schedule; Humans; Levofloxacin; Microspheres; Middle Aged; Ofloxacin; Severity of Illness Index; Treatment Outcome	2005
[Pathogenesis, diagnosis and therapy of Legionella infections]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2006, Volume: 49, Issue:5 Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Antigens, Bacterial; Aza Compounds; Azithromycin; Ciprofloxacin; Diagnosis, Differential; DNA, Bacterial; Fluoroquinolones; Humans; Incidence; Legionella; Legionella pneumophila; Legionellosis; Legionnaires' Disease; Levofloxacin; Moxifloxacin; Ofloxacin; Polymerase Chain Reaction; Quinolines; Serotyping; Virulence	2006
Legionella: macrolides or quinolones? Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006, Volume: 12 Suppl 3 Topics: Animals; Anti-Infective Agents; Azithromycin; Clinical Trials as Topic; Humans; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Quinolones	2006
Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Apr-01, Volume: 44, Issue:7 Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clindamycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Microbial; Female; Fluoroquinolones; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Pelvic Inflammatory Disease; Quinolines; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Treatment Outcome	2007
Diagnosis and treatment of pelvic inflammatory disease. Women's health (London, England), 2008, Volume: 4, Issue:4 Topics: Adult; Anti-Bacterial Agents; Azithromycin; Chlamydia trachomatis; Female; Humans; Infertility, Female; Neisseria gonorrhoeae; Ofloxacin; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic; Risk Factors; Sexually Transmitted Diseases; Ureaplasma; Women's Health	2008
[Pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections]. Nihon rinsho. Japanese journal of clinical medicine, 2009, Volume: 67, Issue:1 Topics: Anti-Bacterial Agents; Azithromycin; Bacteriological Techniques; Cephalosporins; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Drug Therapy, Combination; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Nucleic Acid Amplification Techniques; Ofloxacin; Pharyngitis; Pregnancy; Pregnancy Complications, Infectious; Sexual Behavior	2009
An update on Legionella. Current opinion in infectious diseases, 2010, Volume: 23, Issue:2 Topics: Anti-Bacterial Agents; Antigens, Bacterial; Azithromycin; Community-Acquired Infections; Cross Infection; Germany; Humans; Incidence; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Ofloxacin; United States	2010
Relapsing Legionella pneumophila cellulitis: a case report and review of the literature. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2010, Volume: 16, Issue:6 Topics: Aged; Anti-Bacterial Agents; Azithromycin; Cellulitis; Fatal Outcome; Female; Humans; Immunocompromised Host; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Ofloxacin; Recurrence	2010
Successful approach to treatment of Helicobacter bilis infection in X-linked agammaglobulinemia. Journal of clinical immunology, 2012, Volume: 32, Issue:6 Topics: Adolescent; Adult; Agammaglobulinemia; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Chronic Disease; Ertapenem; Genetic Diseases, X-Linked; Helicobacter; Helicobacter Infections; Humans; Male; Ofloxacin; Phylogeny; Treatment Outcome	2012
[Management of uncomplicated pelvic inflammatory disease]. Journal de gynecologie, obstetrique et biologie de la reproduction, 2012, Volume: 41, Issue:8 Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Chlamydia trachomatis; Drug Resistance, Microbial; Drug Therapy, Combination; Female; France; Gonorrhea; Humans; Metronidazole; Mycoplasma genitalium; Neisseria gonorrhoeae; Ofloxacin; Pelvic Inflammatory Disease; Sexual Partners; Tissue Adhesions	2012
Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women. The Cochrane database of systematic reviews, 2019, Jan-25, Volume: 1 Topics: Anti-Bacterial Agents; Asymptomatic Infections; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Female; Humans; Male; Ofloxacin; Randomized Controlled Trials as Topic; Sex Factors; Treatment Outcome; Urinary Tract Infections	2019
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins. The Cochrane database of systematic reviews, 2022, 11-24, Volume: 11 Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child; Chloramphenicol; Ciprofloxacin; Fluoroquinolones; Humans; Monobactams; Ofloxacin; Pakistan; Paratyphoid Fever; Recurrence; Typhoid Fever	2022

Trials

25 trial(s) available for ofloxacin and zithromax

Article	Year
A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:7 Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Drug Resistance, Multiple; Female; Humans; Male; Nalidixic Acid; Ofloxacin; Outcome Assessment, Health Care; Pilot Projects; Typhoid Fever	2000
A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia. Clinical therapeutics, 2002, Volume: 24, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Azithromycin; Ceftriaxone; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Severity of Illness Index	2002
Efficacy and safety of azithromycin vs levofloxacin in the outpatient treatment of acute bacterial exacerbations of chronic bronchitis. Chest, 2003, Volume: 123, Issue:3 Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Bronchitis, Chronic; Double-Blind Method; Female; Humans; Levofloxacin; Logistic Models; Male; Middle Aged; Multivariate Analysis; Ofloxacin	2003
Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:8 Topics: Adult; Algorithms; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Azithromycin; Blood Urea Nitrogen; Bronchi; Bronchoalveolar Lavage Fluid; Bronchoscopy; Chromatography, High Pressure Liquid; Epithelium; Female; Humans; Injections, Intravenous; Levofloxacin; Lung; Macrophages, Alveolar; Male; Ofloxacin	2003
Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Nov-01, Volume: 37, Issue:9 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Diarrhea; Double-Blind Method; Female; Humans; Levofloxacin; Male; Mexico; Ofloxacin; Travel	2003
Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults. Chest, 2004, Volume: 125, Issue:3 Topics: Aged; Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Azithromycin; Bronchoalveolar Lavage Fluid; Extravascular Lung Water; Female; Fluoroquinolones; Humans; Levofloxacin; Lung; Macrophages, Alveolar; Male; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Urea	2004
Experience with levofloxacin in a critical pathway for the treatment of community-acquired pneumonia. Chemotherapy, 2004, Volume: 50 Suppl 1 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ambulatory Care; Anti-Infective Agents; Azithromycin; Cefuroxime; Community-Acquired Infections; Critical Pathways; Drug Therapy, Combination; Female; Humans; Levofloxacin; Longitudinal Studies; Male; Middle Aged; Ofloxacin; Oxygen Inhalation Therapy; Pneumococcal Infections; Pneumonia; Pneumonia, Bacterial; Treatment Outcome	2004
An ex-vivo pharmacodynamic study comparing bactericidal activity of amoxicillin/sulbactam, azithromycin, doxycycline and levofloxacin against Streptococcus pneumoniae. Journal of chemotherapy (Florence, Italy), 2004, Volume: 16, Issue:3 Topics: Adult; Amoxicillin; Analysis of Variance; Azithromycin; Blood Bactericidal Activity; Colony Count, Microbial; Cross-Over Studies; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Probability; Sensitivity and Specificity; Serum Bactericidal Test; Single-Blind Method; Statistics, Nonparametric; Streptococcus pneumoniae; Sulbactam	2004
Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia. Treatments in respiratory medicine, 2004, Volume: 3, Issue:5 Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Azithromycin; Canada; Ceftriaxone; Community-Acquired Infections; Drug Administration Schedule; Female; Germany; Humans; Infusions, Intravenous; Levofloxacin; Male; Ofloxacin; Pneumonia, Bacterial; Severity of Illness Index; Treatment Outcome; United States	2004
One-week once-daily triple therapy with esomeprazole, levofloxacin and azithromycin compared to a standard therapy for Helicobacter pylori eradication. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2005, Volume: 37, Issue:8 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Patient Compliance; Treatment Outcome	2005
Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2005, Volume: 133, Issue:2 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Chemistry, Pharmaceutical; Confidence Intervals; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; International Cooperation; Levofloxacin; Male; Maxillary Sinusitis; Microspheres; Middle Aged; Ofloxacin; Probability; Risk Assessment; Severity of Illness Index; Treatment Outcome	2005
Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired Pneumonia in adults. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:10 Topics: Adult; Aged; Anti-Bacterial Agents; Azithromycin; Chemistry, Pharmaceutical; Community-Acquired Infections; Double-Blind Method; Female; Humans; Incidence; Levofloxacin; Male; Microspheres; Middle Aged; Ofloxacin; Outpatients; Pneumonia; Serologic Tests; Time Factors; Treatment Outcome	2005
A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial. Chest, 2005, Volume: 128, Issue:5 Topics: Aged; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Community-Acquired Infections; Costs and Cost Analysis; Drug Therapy, Combination; Female; Home Care Services; Hospitalization; Humans; Length of Stay; Levofloxacin; Male; Ofloxacin; Pneumonia, Bacterial; United States	2005
[Levofloxacin-azithromycin combined triple therapy for Helicobacter pylori eradication]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2006, Volume: 47, Issue:1 Topics: Adult; Anti-Bacterial Agents; Azithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin	2006
Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3 Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Blood Cell Count; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Salmonella enterica; Treatment Outcome; Typhoid Fever	2007
Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Feb-01, Volume: 44, Issue:3 Topics: Adult; Anti-Bacterial Agents; Azithromycin; Campylobacter Infections; Campylobacter jejuni; Community-Acquired Infections; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Bacterial; Dysentery; Escherichia coli Infections; Female; Humans; Levofloxacin; Male; Military Personnel; Ofloxacin; Salmonella Infections; Thailand	2007
Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity. Current medical research and opinion, 2007, Volume: 23, Issue:1 Topics: Acute Disease; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Bronchitis, Chronic; Double-Blind Method; Drug Resistance, Bacterial; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Ofloxacin; Severity of Illness Index; Sputum	2007
Azithromycin and loperamide are comparable to levofloxacin and loperamide for the treatment of traveler's diarrhea in United States military personnel in Turkey. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Volume: 45, Issue:3 Topics: Adult; Azithromycin; Campylobacter Infections; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Escherichia coli Infections; Feces; Female; Humans; Levofloxacin; Loperamide; Male; Military Personnel; Nausea; Ofloxacin; Salmonella Infections; Time Factors; Travel; Turkey; United States	2007
Levofloxacin versus azithromycin on the oropharyngeal carriage and selection of antibacterial- resistant streptococci in the microflora of healthy adults. Current medical research and opinion, 2009, Volume: 25, Issue:6 Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Microbial Viability; Ofloxacin; Oropharynx; Streptococcaceae; Streptococcal Infections; Young Adult	2009
Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections. Ophthalmology, 2011, Volume: 118, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Azithromycin; Conjunctiva; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Intravitreal Injections; Levofloxacin; Middle Aged; Moxifloxacin; Nasopharynx; Ofloxacin; Prospective Studies; Quinolines; Staphylococcal Infections	2011
Ophthalmic antibiotic use and multidrug-resistant staphylococcus epidermidis: a controlled, longitudinal study. Ophthalmology, 2011, Volume: 118, Issue:10 Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Choroidal Neovascularization; Conjunctiva; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Follow-Up Studies; Gatifloxacin; Humans; Intravitreal Injections; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Prospective Studies; Quinolines; Staphylococcus epidermidis; Young Adult	2011
Changes in ocular flora in eyes exposed to ophthalmic antibiotics. Ophthalmology, 2013, Volume: 120, Issue:5 Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Bacteria; Choroidal Neovascularization; Conjunctiva; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Intravitreal Injections; Longitudinal Studies; Moxifloxacin; Ofloxacin; Quinolines	2013
Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study. JAMA dermatology, 2013, Volume: 149, Issue:9 Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Azithromycin; CD4-Positive T-Lymphocytes; Chronic Disease; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Rifampin; Sarcoidosis; Severity of Illness Index; Single-Blind Method; Skin Diseases; Transcriptome; Treatment Outcome; Young Adult	2013
Treatment Response in Enteric Fever in an Era of Increasing Antimicrobial Resistance: An Individual Patient Data Analysis of 2092 Participants Enrolled into 4 Randomized, Controlled Trials in Nepal. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Jun-01, Volume: 64, Issue:11 Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Child; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Microbial Sensitivity Tests; Nepal; Ofloxacin; Paratyphoid Fever; Salmonella paratyphi A; Salmonella typhi; Treatment Failure; Treatment Outcome; Typhoid Fever; Young Adult	2017
Treatment of mild-to-moderate pelvic inflammatory disease with a short-course azithromycin-based regimen versus ofloxacin plus metronidazole: results of a multicentre, randomised controlled trial. Sexually transmitted infections, 2021, Volume: 97, Issue:3 Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Drug Therapy, Combination; Female; Humans; Metronidazole; Middle Aged; Mycoplasma genitalium; Ofloxacin; Pelvic Inflammatory Disease; Treatment Outcome; Young Adult	2021

Other Studies

114 other study(ies) available for ofloxacin and zithromax

Article	Year
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human. Xenobiotica; the fate of foreign compounds in biological systems, 2005, Volume: 35, Issue:2 Topics: Administration, Oral; Animals; Area Under Curve; Dogs; Haplorhini; Humans; Models, Statistical; Rats; Software; Species Specificity; Xenobiotics	2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11 Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Outer Membrane Proteins; Down-Regulation; Humans; Macrolides; Membrane Transport Proteins; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing	2008
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1 Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis	2009
Antibiotic susceptibility of Waddlia chondrophila in Acanthamoeba castellanii amoebae. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6 Topics: Acanthamoeba castellanii; Animals; Anti-Bacterial Agents; Chlamydiales; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Quinolones	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium. European journal of medicinal chemistry, 2017, Nov-10, Volume: 140 Topics: Anti-Bacterial Agents; Drug Design; Genistein; Mycobacterium avium; Quinolones	2017
Natural product inspired library synthesis - Identification of 2,3-diarylbenzofuran and 2,3-dihydrobenzofuran based inhibitors of Chlamydia trachomatis. European journal of medicinal chemistry, 2018, Jan-01, Volume: 143 Topics: Anti-Bacterial Agents; Benzofurans; Biological Products; Cell Survival; Chlamydia trachomatis; Dose-Response Relationship, Drug; HeLa Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Small Molecule Libraries; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured	2018
Updates on Chlamydia. Postgraduate medicine, 1992, May-15, Volume: 91, Issue:7 Topics: Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Erythromycin; Humans; Ofloxacin	1992
In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:7 Topics: Anti-Bacterial Agents; Azithromycin; Cells, Cultured; Chlamydophila pneumoniae; Clarithromycin; Erythromycin; Microbial Sensitivity Tests; Ofloxacin	1992
Chlamydia trachomatis: in vitro susceptibility of genital and ocular isolates to some quinolones, amoxicillin and azithromycin. Chemotherapy, 1990, Volume: 36, Issue:6 Topics: Amoxicillin; Anti-Infective Agents; Azithromycin; Cervix Uteri; Chlamydia trachomatis; Ciprofloxacin; Conjunctiva; Drug Evaluation, Preclinical; Erythromycin; Female; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Urethra	1990
Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:5 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteria, Aerobic; Bacteria, Anaerobic; Bites and Stings; Bites, Human; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Wound Infection	1995
Activities of clarithromycin, azithromycin, and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony-stimulating factor against intramacrophage Mycobacterium avium-Mycobacterium intracellulare. The Journal of infectious diseases, 1995, Volume: 172, Issue:3 Topics: Azithromycin; Cells, Cultured; Clarithromycin; Dose-Response Relationship, Drug; Drug Carriers; Drug Interactions; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Kinetics; Liposomes; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Ofloxacin; Recombinant Proteins; Time Factors	1995
A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies. British journal of clinical pharmacology, 1996, Volume: 41, Issue:4 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Ciprofloxacin; Cohort Studies; Drug Prescriptions; Female; Humans; Male; Middle Aged; Norfloxacin; Ofloxacin; Pregnancy; Product Surveillance, Postmarketing; Treatment Outcome	1996
Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:10 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Clarithromycin; Erythromycin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Streptococcus pneumoniae	1996
Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill. Diagnostic microbiology and infectious disease, 1997, Volume: 28, Issue:3 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteriological Techniques; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Sensitivity and Specificity; Species Specificity; Streptococcus pneumoniae	1997
In vitro activity of trovafloxacin against Chlamydia pneumoniae. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:9 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Chlamydophila pneumoniae; Doxycycline; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin	1997
Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones. Journal of clinical microbiology, 1997, Volume: 35, Issue:11 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Charcoal; Ciprofloxacin; Clarithromycin; Culture Media; Erythromycin; Humans; Legionella; Legionella pneumophila; Legionellosis; Microbial Sensitivity Tests; Ofloxacin; Reproducibility of Results; Starch	1997
Legionnaires' disease. The New England journal of medicine, 1998, Jan-15, Volume: 338, Issue:3 Topics: Anti-Infective Agents; Azithromycin; Humans; Imipenem; Legionnaires' Disease; Ofloxacin	1998
Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens. The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:3 Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Bites and Stings; Bites, Human; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Species Specificity; Wound Infection	1998
Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:5 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Erythromycin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae	1998
In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:9 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cells, Cultured; Chlamydophila pneumoniae; Models, Biological; Ofloxacin	1999
National guideline for the management of Chlamydia trachomatis genital tract infection. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). Sexually transmitted infections, 1999, Volume: 75 Suppl 1 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Breast Feeding; Chlamydia Infections; Chlamydia trachomatis; Contact Tracing; Contraindications; Doxycycline; Erythromycin; Female; Humans; Male; Ofloxacin; Pregnancy; Pregnancy Complications, Infectious; Urethritis	1999
National guideline for the management of non-gonococcal urethritis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases) Sexually transmitted infections, 1999, Volume: 75 Suppl 1 Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Chlortetracycline; Contact Tracing; Demeclocycline; Doxycycline; Drug Therapy, Combination; Erythromycin; Humans; Male; Ofloxacin; Recurrence; Tetracycline; Urethritis	1999
Association of chronic urinary symptoms in women and Ureaplasma urealyticum. Urology, 2000, Volume: 55, Issue:4 Topics: Adolescent; Adult; Aged; Azithromycin; Bacteriological Techniques; Bacteriuria; Chronic Disease; Cystitis, Interstitial; Doxycycline; Erythromycin; Female; Humans; Middle Aged; Ofloxacin; Treatment Outcome; Ureaplasma Infections; Ureaplasma urealyticum; Urination Disorders	2000
Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. The Journal of infectious diseases, 2000, Volume: 181, Issue:4 Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Disease Transmission, Infectious; Drug Resistance, Multiple; Female; Humans; Male; Microbial Sensitivity Tests; Ofloxacin; Pregnancy; Pregnancy Complications, Infectious; Urethritis	2000
Efficacy of SCH27899 in an animal model of Legionnaires' disease using immunocompromised A/J mice. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:5 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cortisone; Disease Models, Animal; Female; Immunocompromised Host; Legionella pneumophila; Legionnaires' Disease; Lung; Mice; Ofloxacin	2000
Activities of antimicrobial agents against intracellular pneumococci. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:9 Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Fluoroquinolones; Gentamicins; Humans; Ketolides; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Penicillin G; Quinolines; Rifampin; Streptococcus pneumoniae; Tumor Cells, Cultured	2000
Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 31, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteremia; Drug Resistance, Microbial; Drug Resistance, Multiple; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pneumonia, Pneumococcal; Streptococcus pneumoniae	2000
Rhodococcus equi and cytomegalovirus pneumonia in a renal transplant patient: diagnosis by fine-needle aspiration biopsy. Diagnostic cytopathology, 2001, Volume: 24, Issue:2 Topics: Actinomycetales Infections; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antigens, Viral; Antiviral Agents; Azithromycin; Biopsy, Needle; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Humans; Immunocompromised Host; Kidney Transplantation; Male; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Viral; Postoperative Complications; Rhodococcus; Tomography, X-Ray Computed; Vancomycin	2001
In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:8 Topics: Animals; Anti-Infective Agents; Area Under Curve; Azithromycin; Body Weight; Fluoroquinolones; Gemifloxacin; Guinea Pigs; Half-Life; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Lung; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Survival Rate	2001
Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection Model. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:2 Topics: Anti-Bacterial Agents; Azithromycin; Chlamydophila pneumoniae; Clarithromycin; Cytokines; Humans; Levofloxacin; Microbial Sensitivity Tests; Models, Biological; Ofloxacin; Tumor Cells, Cultured	2002
Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2000, Volume: 6, Issue:1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Proteins; Ceftazidime; Cephalosporins; Clarithromycin; Clindamycin; Erythromycin; In Vitro Techniques; Josamycin; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Oleandomycin; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Time Factors; Tobramycin	2000
[Changes of antibody titers during antimicrobial therapy including levofloxacin for Chlamydia infections in the obstetrics and gynecology field]. The Japanese journal of antibiotics, 2002, Volume: 55, Issue:2 Topics: Antibodies, Bacterial; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Drug Therapy, Combination; Female; Humans; Immunoglobulin G; Levofloxacin; Maternal-Fetal Exchange; Ofloxacin; Pregnancy; Pregnancy Complications, Infectious	2002
Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000. Diagnostic microbiology and infectious disease, 2002, Volume: 43, Issue:3 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Child; Ciprofloxacin; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae; United States	2002
[Effect of azithromycin on cytokine production by THP-1 cells]. The Japanese journal of antibiotics, 2001, Volume: 54 Suppl C Topics: Anti-Bacterial Agents; Azithromycin; Cells, Cultured; Depression, Chemical; Dose-Response Relationship, Drug; Humans; Interleukin-12; Lipopolysaccharides; Monocytes; Ofloxacin; Tumor Necrosis Factor-alpha	2001
A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex. Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Colony Count, Microbial; Erythromycin; Microbial Sensitivity Tests; Mycobacterium fortuitum; Ofloxacin; Tetracycline	2002
In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:3 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila pneumoniae; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rifamycins	2003
[Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori]. The Japanese journal of antibiotics, 2002, Volume: 55, Issue:6 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Gastric Mucosa; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Penicillins; Stomach Ulcer	2002
Antibiotic therapy for ambulatory patients with community-acquired pneumonia in an emergency department setting. Archives of internal medicine, 2003, Apr-14, Volume: 163, Issue:7 Topics: Adolescent; Adult; Aged; Alberta; Ambulatory Care; Analysis of Variance; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Emergency Service, Hospital; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Treatment Outcome	2003
Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:6 Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Azithromycin; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Lactams; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Ofloxacin; Pneumococcal Infections; Prospective Studies; Respiratory Tract Infections; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination; United States	2003
Alterations in penicillin binding protein gene of Streptococcus pneumoniae and their correlation with susceptibility patterns. International journal of antimicrobial agents, 2003, Volume: 22, Issue:2 Topics: Aminoacyltransferases; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Carrier Proteins; Clarithromycin; Drug Resistance, Bacterial; Genes, Bacterial; Hexosyltransferases; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Mutation; Ofloxacin; Penicillin G; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases; Pneumococcal Infections; Streptococcus pneumoniae; Thienamycins	2003
[Detection of bacterial 16S rRAN gene in EPS of men with chronic pelvic pain syndrome and its clinical significance]. Zhonghua nan ke xue = National journal of andrology, 2003, Volume: 9, Issue:4 Topics: Anti-Bacterial Agents; Azithromycin; Chronic Disease; Humans; Levofloxacin; Male; Ofloxacin; Pelvic Pain; Polymerase Chain Reaction; Prostatitis; RNA, Bacterial; RNA, Ribosomal, 16S	2003
[Susceptibility of major pathogens of acute pharyngitis and tonsillitis to levofloxacin and other oral antimicrobial drugs]. The Japanese journal of antibiotics, 2003, Volume: 56, Issue:3 Topics: Acute Disease; Ampicillin; Anti-Infective Agents; Azithromycin; Cefdinir; Cefpodoxime; Ceftizoxime; Cephalosporins; Clarithromycin; Enterobacteriaceae; Haemophilus influenzae; Humans; Levofloxacin; Ofloxacin; Penicillin G; Pharyngitis; Streptococcus pneumoniae; Streptococcus pyogenes; Tonsillitis	2003
Susceptibility of mixed infection of Ureaplasma Urealyticum and Mycoplasma Hominis to seven antimicrobial agents and comparison with that of Ureaplasma Urealyticum infection. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2003, Volume: 23, Issue:2 Topics: Adult; Anti-Bacterial Agents; Azithromycin; Doxycycline; Drug Resistance, Bacterial; Female; Humans; Josamycin; Male; Middle Aged; Minocycline; Mycoplasma hominis; Mycoplasma Infections; Ofloxacin; Superinfection; Ureaplasma Infections; Ureaplasma urealyticum	2003
[New achievements in the diagnosis and treatment of disseminated urogenital chlamydiosis]. Vestnik Rossiiskoi akademii meditsinskikh nauk, 2003, Issue:10 Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Chlamydia Infections; Ciprofloxacin; Diagnosis, Differential; Doxycycline; Drug Therapy, Combination; Female; Fluorescent Antibody Technique, Direct; Fluorescent Antibody Technique, Indirect; Humans; Immunoenzyme Techniques; Josamycin; Male; Ofloxacin; Radionuclide Imaging; Time Factors; Treatment Outcome	2003
Effects of eight antibacterial agents on cell survival and expression of epithelial-cell- or cell-adhesion-related genes in human gingival epithelial cells. Journal of periodontal research, 2004, Volume: 39, Issue:1 Topics: Anti-Bacterial Agents; Azithromycin; Cell Adhesion; Cell Differentiation; Cell Division; Cell Line; Cell Survival; Clarithromycin; Enoxacin; Epithelial Cells; Erythromycin; Fibroblast Growth Factors; Gingiva; Humans; Integrins; Keratins; Laminin; Lethal Dose 50; Minocycline; Ofloxacin; Proteins; Roxithromycin; Tetracycline	2004
Comparative in vitro activities of three new quinolones and azithromycin against aerobic pathogens causing respiratory tract and abdominal wound infections. Chemotherapy, 2004, Volume: 50, Issue:1 Topics: Abdominal Injuries; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Bacteria, Aerobic; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Respiratory Tract Infections; Wound Infection	2004
In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:5 Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila pneumoniae; Folic Acid Antagonists; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pyrimidines	2004
[Equally whether the child's lung or chronically inflamed bronchi. Acute bacterial infections have to be terminated fast]. MMW Fortschritte der Medizin, 2004, Mar-11, Volume: 146, Issue:11 Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bronchitis, Chronic; Child; Clinical Trials as Topic; Double-Blind Method; Erythromycin; Humans; Middle Aged; Multicenter Studies as Topic; Ofloxacin; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Radiography, Thoracic; Randomized Controlled Trials as Topic; Time Factors	2004
The in vitro activity of a new fluoroquinolone, ABT-492, against recent clinical isolates of Chlamydia pneumoniae. The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Chlamydia Infections; Chlamydophila pneumoniae; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones	2004
Streptococcus pneumoniae in vitro development of resistance to amoxicillin/clavulanic acid, cefaclor, levofloxacin and azithromycin. International journal of antimicrobial agents, 2004, Volume: 24, Issue:2 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefaclor; Culture Media; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae	2004
Bactericidal activity of moxifloxacin against multidrug-resistant Streptoccocus pneumoniae at clinically achievable serum and epithelial lining fluid concentrations compared with three other antimicrobials. International journal of antimicrobial agents, 2004, Volume: 24, Issue:4 Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Streptococcus pneumoniae	2004
Salvage of a prosthetic knee joint infected with resistant pneumococcus. A case report. The Journal of bone and joint surgery. American volume, 2004, Volume: 86, Issue:10 Topics: Aged; Anti-Infective Agents; Arthritis, Infectious; Arthroplasty, Replacement, Knee; Azithromycin; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Male; Ofloxacin; Pneumococcal Infections; Prosthesis-Related Infections; Rifampin; Vancomycin	2004
Glucocorticoids increase in vitro and in vivo activities of antibiotics against Chlamydophila pneumoniae. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:12 Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Cell Line; Chlamydophila Infections; Chlamydophila pneumoniae; Dexamethasone; Drug Synergism; Glucocorticoids; Humans; Ketolides; Levofloxacin; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Ofloxacin	2004
Comparative bacteriological efficacy of pharmacokinetically enhanced amoxicillin-clavulanate against Streptococcus pneumoniae with elevated amoxicillin MICs and Haemophilus influenzae. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:3 Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Azithromycin; Clavulanic Acid; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rats; Rats, Sprague-Dawley; Streptococcus pneumoniae	2005
An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care. Current medical research and opinion, 2005, Volume: 21, Issue:2 Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Databases as Topic; Erythromycin; Female; Health Care Costs; Humans; Levofloxacin; Male; Managed Care Programs; Middle Aged; Models, Econometric; Ofloxacin; Pneumonia, Bacterial; Retrospective Studies; Risk Assessment; Treatment Outcome	2005
In vitro selection of resistance to clarithromycin in Streptococcus pneumoniae clinical isolates. Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:2 Topics: Amoxicillin; Aza Compounds; Azithromycin; Clarithromycin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Sampling Studies; Sensitivity and Specificity; Streptococcus pneumoniae	2005
The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens. Journal of general internal medicine, 2005, Volume: 20, Issue:7 Topics: Administration, Oral; Aged; Anti-Infective Agents; Anticoagulants; Azithromycin; Cohort Studies; Drug Interactions; Female; Humans; International Normalized Ratio; Levofloxacin; Male; Ofloxacin; Platelet Aggregation Inhibitors; Prazosin; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Warfarin	2005
Editorial commentary: dilemma in trial design: do current study designs adequately evaluate effectiveness antibiotic in ABRS? Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2005, Volume: 133, Issue:2 Topics: Acute Disease; Azithromycin; Bacterial Infections; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Maxillary Sinusitis; Microspheres; Ofloxacin; Randomized Controlled Trials as Topic; Rhinitis; Risk Assessment; Severity of Illness Index; Treatment Outcome	2005
What's in a day? Chest, 2005, Volume: 128, Issue:5 Topics: Anti-Bacterial Agents; Azithromycin; Community-Acquired Infections; Humans; Length of Stay; Ofloxacin; Pneumonia, Bacterial; United States	2005
Value of short-course antimicrobial therapy in acute bacterial rhinosinusitis. International journal of antimicrobial agents, 2005, Volume: 26 Suppl 3 Topics: Acute Disease; Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Microspheres; Middle Aged; Ofloxacin; Rhinitis; Sinusitis; Time Factors; Treatment Outcome	2005
[Prevalence and treatment of pharyngeal Chlamydia trachomatis infections]. The Japanese journal of antibiotics, 2006, Volume: 59, Issue:1 Topics: Adult; Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Female; Humans; Japan; Levofloxacin; Ofloxacin; Pharyngitis; Prevalence; Sex Work; Sexual Behavior; Uterine Diseases	2006
Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Cefuroxime; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Genes, Bacterial; Levofloxacin; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae	2006
Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (Polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin against Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6 Topics: Anti-Bacterial Agents; Azithromycin; Ceftazidime; Colistin; Dose-Response Relationship, Drug; Drug Synergism; In Vitro Techniques; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Mutation; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Thienamycins; Tobramycin	2006
A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia. The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:2 Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Mutation; Ofloxacin; Pneumonia, Pneumococcal; Quinolines; Serum Bactericidal Test; Streptococcus pneumoniae	2006
Occurrence of levofloxacin, clarithromycin and azithromycin in wastewater treatment plant in Japan. Water science and technology : a journal of the International Association on Water Pollution Research, 2006, Volume: 53, Issue:11 Topics: Anti-Bacterial Agents; Azithromycin; Chromatography, Liquid; Clarithromycin; Conservation of Natural Resources; Japan; Levofloxacin; Mass Spectrometry; Ofloxacin; Sewage; Time Factors; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Purification	2006
Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes. Diabetes research and clinical practice, 2007, Volume: 76, Issue:1 Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fluoroquinolones; Humans; Male; Mexican Americans; Moxifloxacin; Neutrophils; Ofloxacin; Protein Kinase C; Quinolines; Respiratory Burst; Superoxides; Tetradecanoylphorbol Acetate; Zymosan	2007
Severe Legionnaires' disease successfully treated with levofloxacin and azithromycin. Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:5 Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Drug Therapy, Combination; Female; Humans; Legionnaires' Disease; Levofloxacin; Lung; Middle Aged; Ofloxacin; Radiography; Remission Induction	2006
Azithromycin for the self-treatment of traveler's diarrhea. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Feb-01, Volume: 44, Issue:3 Topics: Anti-Bacterial Agents; Azithromycin; Campylobacter Infections; Campylobacter jejuni; Community-Acquired Infections; Doxycycline; Drug Resistance, Bacterial; Dysentery; Humans; Ofloxacin; Self Administration; Travel	2007
Determination of six anti-infectives in wastewater using tandem solid-phase extraction and liquid chromatography-tandem mass spectrometry. Journal of environmental monitoring : JEM, 2007, Volume: 9, Issue:4 Topics: Anti-Infective Agents; Azithromycin; Chromatography, Liquid; Ciprofloxacin; Clarithromycin; Ofloxacin; Sewage; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Trimethoprim; Water Pollutants, Chemical	2007
Evidence of efficacy is not enough to develop recommendations: antibiotics for treatment of traveler's diarrhea. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jun-01, Volume: 44, Issue:11 Topics: Anti-Bacterial Agents; Azithromycin; Diarrhea; Drug Resistance, Bacterial; Humans; Military Personnel; Ofloxacin; Thailand; Travel	2007
Multidrug-induced erythema multiforme. Journal of investigational allergology & clinical immunology, 2007, Volume: 17, Issue:3 Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Hypersensitivity; Erythema Multiforme; Female; Humans; Levofloxacin; Methenamine; Ofloxacin; Piroxicam; Skin Tests; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2007
Capability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologies. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11 Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Clindamycin; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Imipenem; Ketolides; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae	2007
Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting. Pharmacotherapy, 2008, Volume: 28, Issue:1 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Creatinine; Diabetes Complications; Female; Fluoroquinolones; Gatifloxacin; Hospitals, Veterans; Humans; Hyperglycemia; Hypoglycemia; Levofloxacin; Male; Medical Records; Middle Aged; Multivariate Analysis; Ofloxacin; Prevalence; Retrospective Studies; Rhode Island; Risk Factors	2008
Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial. Clinical therapeutics, 2007, Volume: 29, Issue:12 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Randomized Controlled Trials as Topic; Retrospective Studies; Rhinitis; Sinusitis; Treatment Outcome	2007
Levofloxacin vs. azithromycin pharmacodynamic activity against S. pneumoniae and H. influenzae with decreased susceptibility to amoxicillin/clavulanic acid. Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:6 Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Clavulanic Acid; Computer Simulation; Drug Resistance, Bacterial; Haemophilus influenzae; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae	2007
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Cefepime; Cefotaxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Egypt; Hawaii; Humans; Leptospira; Leptospirosis; Levofloxacin; Microbial Sensitivity Tests; Nicaragua; Ofloxacin; Tetracycline; Thailand	2008
[Levofloxacin and macrolides in chronic bronchitis exacerbation: comparative analysis of the treatment efficacy and nonrelapsing periods]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2007, Volume: 52, Issue:7-8 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Bronchitis, Chronic; Clarithromycin; Female; Humans; Levofloxacin; Macrolides; Male; Middle Aged; Ofloxacin; Treatment Outcome; Young Adult	2007
Arthritis caused by Mycobacterium terrae in a patient with rheumatoid arthritis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2009, Volume: 13, Issue:4 Topics: Adult; Anti-Bacterial Agents; Arthritis, Rheumatoid; Azithromycin; Drug Therapy, Combination; Ethambutol; Humans; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Treatment Outcome	2009
Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: a US-based study. Current medical research and opinion, 2009, Volume: 25, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Community-Acquired Infections; Drug Therapy, Combination; Female; Health Resources; Humans; Least-Squares Analysis; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Practice Guidelines as Topic; Societies, Medical; United States	2009
[Voice on the treatment of ureaplasmas infections]. Przeglad epidemiologiczny, 2009, Volume: 63, Issue:1 Topics: Anti-Infective Agents; Azithromycin; Dose-Response Relationship, Drug; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Ureaplasma; Ureaplasma Infections; Ureaplasma urealyticum	2009
Clinical and economic outcomes in respiratory tract infections: The impact of bacterial resistance. Postgraduate medicine, 2002, Volume: 112, Issue:3 Suppl Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Community-Acquired Infections; Doxycycline; Drug Resistance, Multiple, Bacterial; Humans; Kentucky; Levofloxacin; Ofloxacin; Pneumonia, Bacterial; Respiratory Tract Infections; Streptococcus pneumoniae; Treatment Outcome; United States	2002
Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. The New England journal of medicine, 2009, Dec-24, Volume: 361, Issue:26 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Child; Child, Preschool; China; Disease Outbreaks; Drug Therapy, Combination; Female; Humans; Incidence; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Logistic Models; Lymphopenia; Male; Middle Aged; Ofloxacin; Oseltamivir; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Time Factors; Virus Shedding; Young Adult	2009
CEM-101 activity against Gram-positive organisms. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Gentamicins; Gram-Positive Bacteria; Ketolides; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin	2010
Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2010, Volume: 14, Issue:4 Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Chi-Square Distribution; Clarithromycin; Community-Acquired Infections; Female; Humans; Kaplan-Meier Estimate; Legionella pneumophila; Legionnaires' Disease; Length of Stay; Levofloxacin; Male; Ofloxacin; Retrospective Studies; Time Factors; Treatment Outcome	2010
In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Anti-Infective Agents; Azithromycin; Chlamydia trachomatis; Clarithromycin; Doxycycline; Erythromycin; Genotype; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin	2010
[Clinical features and delayed aftereffects of Legionellosis pneumonia during an epidemic outbreak]. Klinicheskaia meditsina, 2010, Volume: 88, Issue:4 Topics: Anti-Bacterial Agents; Azithromycin; Disease Outbreaks; Female; Humans; Legionellosis; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Russia; Treatment Outcome; Water Supply	2010
Eradication of Chlamydia trachomatis parallels symptom regression in chronic bacterial prostatitis patients treated with a fluoroquinolone-macrolide combination. Andrologia, 2010, Volume: 42, Issue:6 Topics: Adult; Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Drug Therapy, Combination; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostate-Specific Antigen; Prostatitis; Semen; Urethra	2010
Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Humans; Leukocyte Count; Levofloxacin; Male; Middle Aged; Mycoplasma genitalium; Mycoplasma Infections; Ofloxacin; Treatment Outcome; Ureaplasma Infections; Ureaplasma urealyticum; Urethritis; Young Adult	2011
In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4 Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bridged-Ring Compounds; Cell Line; Cells, Cultured; Clarithromycin; Disease Models, Animal; Humans; Ketolides; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Macrolides; Mice; Microbial Sensitivity Tests; Ofloxacin	2011
Antibacterial and synergy of a flavanonol rhamnoside with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). Phytomedicine : international journal of phytotherapy and phytopharmacology, 2011, Aug-15, Volume: 18, Issue:11 Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Ceftazidime; Drug Synergism; Flavonols; Glycosides; Humans; Hypericum; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Ofloxacin; Quercetin; Sputum	2011
[Regional difference of antibiotic resistance of helicobacter pylori strains in Korea]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2011, Volume: 57, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Republic of Korea; Tetracycline	2011
Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin. Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:2 Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Doxycycline; Erythromycin; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Reproducibility of Results; Roxithromycin; Tetracycline; Time Factors; Ureaplasma Infections; Ureaplasma urealyticum	2011
Highly resistant Salmonella enterica serovar Typhi with a novel gyrA mutation raises questions about the long-term efficacy of older fluoroquinolones for treating typhoid fever. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5 Topics: Adolescent; Amino Acid Sequence; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Nepal; Ofloxacin; Salmonella typhi; Treatment Failure; Typhoid Fever	2012
Antibacterial and synergy of berberines with antibacterial agents against clinical multi-drug resistant isolates of methicillin-resistant Staphylococcus aureus (MRSA). Molecules (Basel, Switzerland), 2012, Aug-29, Volume: 17, Issue:9 Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Berberine; Cefazolin; Drug Combinations; Drug Interactions; Drug Resistance, Multiple, Bacterial; Drug Synergism; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Ofloxacin	2012
[Diagnostic and treatment patterns in management of male patients with nongonococcal urethritis: results of Russian multicentral cross-sectional study]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2012, Volume: 57, Issue:5-6 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antiprotozoal Agents; Azithromycin; Ceftriaxone; Chlamydia trachomatis; Cross-Sectional Studies; Doxycycline; Fluconazole; Guideline Adherence; Humans; Josamycin; Male; Metronidazole; Middle Aged; Mycoplasma genitalium; Mycoplasma hominis; Ofloxacin; Polymerase Chain Reaction; Practice Guidelines as Topic; Retrospective Studies; Russia; Trichomonas vaginalis; Ureaplasma urealyticum; Urethra; Urethritis	2012
Ureaplasma serovars & their antimicrobial susceptibility in patients of infertility & genital tract infections. The Indian journal of medical research, 2012, Volume: 136, Issue:6 Topics: Adult; Anti-Infective Agents; Azithromycin; Doxycycline; Female; Humans; Infertility; Josamycin; Male; Microbial Sensitivity Tests; Ofloxacin; Polymerase Chain Reaction; Reproductive Tract Infections; Serotyping; Species Specificity; Ureaplasma; Ureaplasma Infections	2012
Influence of sub-inhibitory antibiotics and flow condition on Staphylococcus aureus ATCC 6538 biofilm development and biofilm growth rate: BioTimer assay as a study model. The Journal of antibiotics, 2014, Volume: 67, Issue:11 Topics: Anti-Bacterial Agents; Azithromycin; Biofilms; Gentamicins; Microbial Sensitivity Tests; Models, Theoretical; Ofloxacin; Staphylococcal Infections; Staphylococcus aureus	2014
Antimicrobial Susceptibility of Microorganisms Isolated from Periapical Periodontitis Lesions. The Bulletin of Tokyo Dental College, 2016, Volume: 57, Issue:3 Topics: Actinomyces; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Biofilms; Campylobacter; Cefmetazole; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Fusobacteria; Haemophilus; Humans; Klebsiella; Microbial Sensitivity Tests; Ofloxacin; Periapical Periodontitis; Porphyromonas; Propionibacterium; Staphylococcus hominis; Veillonella	2016
Surface plasmon resonance sensor for antibiotics detection based on photo-initiated polymerization molecularly imprinted array. Talanta, 2016, Dec-01, Volume: 161 Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Cross-Linking Reagents; Methacrylates; Molecular Imprinting; Ofloxacin; Penicillins; Polymerization; Succinates; Surface Plasmon Resonance; Ultraviolet Rays	2016
[Chlamydia trachomatis]. Annales de dermatologie et de venereologie, 2016, Volume: 143, Issue:11 Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; DNA, Bacterial; Doxycycline; Female; Humans; Male; Nucleic Acid Amplification Techniques; Ofloxacin	2016
[Donovanosis (granuloma inguinale)]. Annales de dermatologie et de venereologie, 2016, Volume: 143, Issue:11 Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia trachomatis; Ciprofloxacin; Erythromycin; Granuloma Inguinale; Humans; Ofloxacin	2016
Antibiotic treatment patterns, costs, and resource utilization among patients with community acquired pneumonia: a US cohort study. Hospital practice (1995), 2017, Volume: 45, Issue:1 Topics: Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Retrospective Studies; Risk Assessment	2017
Outbreak of acute undifferentiated febrile illness in Kathmandu, Nepal: clinical and epidemiological investigation. BMC infectious diseases, 2020, Jan-30, Volume: 20, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefixime; Child; Disease Outbreaks; Female; Fever; Humans; Male; Middle Aged; Nepal; Ofloxacin; Risk Factors; Typhoid Fever; Virus Diseases; Young Adult	2020
Antibiotics in sewage treatment plants, receiving water bodies and groundwater of Chennai city and the suburb, South India: Occurrence, removal efficiencies, and risk assessment. The Science of the total environment, 2022, Dec-10, Volume: 851, Issue:Pt 2 Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Environmental Monitoring; Erythromycin; Fluoroquinolones; Groundwater; India; Macrolides; Ofloxacin; Risk Assessment; Sewage; Sulfamethazine; Tetracyclines; Water; Water Pollutants, Chemical	2022
[Pollution Characteristics and Risk Assessment of Antibiotics in Beiyun River Basin in Beijing]. Huan jing ke xue= Huanjing kexue, 2023, Jun-08, Volume: 44, Issue:6 Topics: Anti-Bacterial Agents; Azithromycin; Beijing; Clarithromycin; Erythromycin; Lincomycin; Ofloxacin; Risk Assessment; Rivers; Roxithromycin; Sulfapyridine; Tandem Mass Spectrometry	2023